Nova Patents
IL252405B

Treatment of diseases associated with hepatic stellate cell activation using ammonia-lowering therapies

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Published
  4. Today

46 members in 18 offices

This recordMember, by publication datePriority claim8 more offices are in the list below

Priority claims8

Priority claims
DocumentOfficeKindDate
201462083814United States of AmericaP
201462083814United States of AmericaP
2015062223United States of AmericaW
2015062223United States of AmericaW
62083814–––
PCTUS2015062223–––
US201462083814P–––
WO2015US62223–––

Members46

Family members, oldest first
DocumentOfficeKind
CA2968544A1CanadaA1
WO2016085887A1World Intellectual Property Organization (WIPO)A1
AU2015353703A1AustraliaA1
SG11201704011XASingaporeA
IL252405A0IsraelA0
IL252405D0IsraelD0
KR20170095894ARepublic of KoreaA
CN107206021AChinaA
EP3223829A1European Patent Office (EPO)A1
EA201790913A1Eurasian Patent Organization (EAPO)A1
JP2017535575AJapanA
US2017354627A1United States of AmericaA1
BR112017010761A2BrazilA2
MX2017006685AMexicoA
EP3223829A4European Patent Office (EPO)A4
HK1243651AHong Kong, ChinaA
HK1243651A1Hong Kong, ChinaA1
US10039735B2United States of AmericaB2
US2019070142A1United States of AmericaA1
EP3223829B1European Patent Office (EPO)B1
US10525029B2United States of AmericaB2
DK3223829T3DenmarkT3
ES2769000T3SpainT3
US2020206175A1United States of AmericaA1
EP3685841A1European Patent Office (EPO)A1
JP2020169180AJapanA
MX2020010194AMexicoA
MX2020010194AMexicoA
JP6797117B2JapanB2
IL252405AIsraelA
IL252405BThis recordIsraelB
AU2015353703B2AustraliaB2
IL281349AIsraelA
IL281349D0IsraelD0
US11040021B2United States of AmericaB2
AU2021203938A1AustraliaA1
NZ732632ANew ZealandA
CN107206021BChinaB
ZA201703779BSouth AfricaB
CN113633777AChinaA
IL281349BIsraelB
BR112017010761B1BrazilB1
JP7199400B2JapanB2
KR102487376B1Republic of KoreaB1
KR20230018526ARepublic of KoreaA
MX375838BMexicoB